未登录

T

Ting-Shi Su

Guangxi Medical University

H指数:19

被引数:1,033

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic Metabolomics Atlas of Radiation-induced Liver Injury and Hepatocyte Proliferation Process in Rat

辐射诱导的肝损伤及肝细胞增殖过程的动态代谢组学图谱

Radiation Research

IF2.7

2026-01-010

PRE

Evaluation of organ-specific relative biological effectiveness of proton therapy using radiation-induced pneumonitis as an endpoint

以放射性肺炎为终点评估质子治疗器官特异性相对生物效应

Clinical and Translational Radiation Oncology

IF2.7

2025-12-010

OAAI

Single-cell transcriptome sequencing reveals hepatocyte heterogeneity in response to radiation-induced liver injury

单细胞转录组测序揭示了肝细胞在辐射诱导的肝脏损伤中的异质性

Radiotherapy and Oncology

IF5.3

2025-10-250

PRE

PPARγ Modulation of Hepatic Stellate Cell-Hepatocyte Crosstalk Enhances Liver Regeneration Post-Radiation Injury via IL-6 and HGF Signaling

PPARγ对肝星状细胞-肝细胞通讯的调控通过IL-6和HGF信号通路增强辐射损伤后的肝脏再生

International Journal of Radiation Oncology*Biology*Physics

IF0

2025-10-220

PRE

Differentiation Stage Predicts Radiosensitivity in Mesenchymal-Like Pancreatic Cancer

分化阶段预测类间充质胰腺癌的放射敏感性

international journal of radiation oncology biology physics

IF0

2025-04-010

PRE

Radiofrequency Ablation Therapy versus Stereotactic Body Radiation Therapy for Naive Hepatocellular Carcinoma (≤5cm): A Retrospective Multi-Center Study

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2024-11-011

OAAI

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2024-02-0120

OAAI

Comprehensive analysis of the role of Netrin G1 (NTNG1) in hepatocellular carcinoma cells

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2024-01-011

PRE

Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma

RADIATION ONCOLOGY

IF3.2

2023-08-042

OAAI

Liver regeneration after radiation therapy: clinical observations and a new rat model

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial

HEPATOLOGY INTERNATIONAL

IF6.1

2022-08-2416

OAAI

Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study

RADIATION ONCOLOGY

IF3.2

2022-06-1110

OAAI

New Staging Model for Radiation-based Hepatocellular Carcinoma Treatment: A National Multicenter Study

clinical and translational gastroenterology

IF4.2

2022-05-242

OAAI

Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting

放化疗与单纯化疗治疗晚期食管鳞状细胞癌: 转移性原发肿瘤确定性放疗的作用

FRONTIERS IN ONCOLOGY

IF3.3

2022-03-309

OAAI

A Prospective Study of Liver Regeneration After Radiotherapy Based on a New (Su'S) Target Area Delineation

FRONTIERS IN ONCOLOGY

IF3.3

2021-08-268

OAAI

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-084

OAAI

Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

RADIATION ONCOLOGY

IF3.2

2021-04-2119

OAAI

Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis

HEPATOLOGY INTERNATIONAL

IF6.1

2021-04-0521

OA

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2020-12-1416

OAAI

Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion

FRONTIERS IN ONCOLOGY

IF3.3

2020-07-3112

OAAI